EvlaBio

EvlaBio is a biotechnology company operator dedicated to advancing the industrialization of drug development to improve lives. The company focuses on the development of drug programs and provides a pipeline composed of robust scientific antibody projects for the treatment of hepatocellular carcinoma, chronic kidney disease, and left ventricular hypertrophy, enabling clients to reduce costs and shorten the time to deliver new drugs to patients.